Acadia Healthcare Details CEO Separation Package, Reveals Legal Investigation Support

summarizeSummary

Acadia Healthcare disclosed the financial terms of former CEO Christopher H. Hunter's separation, including a significant payout and the company's agreement to advance legal costs for him in ongoing DOJ and SEC investigations.

check_boxKey Events

• CEO Separation Terms Finalized

  The company entered into a separation and release agreement with former CEO Christopher H. Hunter, effective January 20, 2026, detailing the financial terms of his departure.

• Substantial Separation Payout

  Mr. Hunter will receive a $1,785,000 lump sum cash payment for a retention bonus, 1.5 times the sum of his base salary and 2025 target annual bonus paid over 18 months, and 18 months of after-tax health and dental insurance premiums.

• Legal Investigation Support Disclosed

  Acadia Healthcare agreed to advance certain legal costs for Mr. Hunter related to pending investigations by the U.S. Department of Justice and the U.S. Securities and Exchange Commission.

• Equity Forfeiture

  Most unvested equity awards held by Mr. Hunter were immediately forfeited, with only a prorated portion of performance-based restricted stock units (PSUs) remaining eligible to vest.

auto_awesomeAnalysis

This 8-K provides critical financial details regarding the separation of former CEO Christopher H. Hunter, following the initial announcement of his immediate departure on January 20, 2026. The substantial separation package, including a $1.785 million retention bonus and 1.5 times his base salary and target bonus, represents a significant cost to the company. More importantly, the filing reveals that Acadia Healthcare will advance legal costs for Mr. Hunter in connection with pending investigations by the U.S. Department of Justice and the U.S. Securities and Exchange Commission. This disclosure of ongoing regulatory scrutiny is a material negative development that could impact investor perception and future operational risks.